M Hammoudeh. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/drug therapyFemaleHumansInfliximabKidney Failure, Chronic/complicationsMiddle AgedRenal DialysisTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Antibodies, MonoclonalAntirheumatic AgentsTumor Necrosis Factor-alphaInfliximab
Year: 2005 PMID: 16368727 DOI: 10.1093/rheumatology/kei264
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580